+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid



In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid



Antimicrobial Agents and ChemoTherapy 31(1): 132-133



The in vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium africanum, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae (M. chelonei) to ticarcillin in combination with calvulanic acid (CA) was studied by the agar dilution method. All the M. tuberculosis, M. bovis, and M. africanum strains were inhibited at a ticarcillin concentration of 32 micrograms/ml or lower in combination with 5 micrograms of CA. M. chelonae and M. avium strains proved resistant to more than 128 micrograms of ticarcillin plus 5 micrograms of CA per ml. M. fortuitum strains needed 128 micrograms of ticarcillin plus 5 micrograms of CA to inhibit approximately 30% of the isolates.

(PDF emailed within 0-6 h: $19.90)

Accession: 005652259

Download citation: RISBibTeXText

PMID: 3105441

DOI: 10.1128/aac.31.1.132


Related references

In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid. Journal of Antimicrobial ChemoTherapy 22(6): 863-866, 1988

Phylogenomic analysis of the species of the Mycobacterium tuberculosis complex demonstrates that Mycobacterium africanum, Mycobacterium bovis, Mycobacterium caprae, Mycobacterium microti and Mycobacterium pinnipedii are later heterotypic synonyms of Mycobacterium tuberculosis. International Journal of Systematic and Evolutionary Microbiology 68(1): 324-332, 2017

In vitro activities of norfloxacin and ciprofloxacin against mycobacterium tuberculosis mycobacterium avium complex mycobacterium chelonei mycobacterium fortuitum and mycobacterium kansasii. Antimicrobial Agents & Chemotherapy 26(1): 94-96, 1984

Deoxyribonucleic Acid Relatedness Among Selected Strains of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium bovis Bcg, Mycobacterium microti, and Mycobacterium africanum. International Journal of Systematic Bacteriology 35(2): 147-150, 1985

Infections with mycobacterium avium human mycobacterium bovis mycobacterium tuberculosis mycobacterium kansasii mycobacterium intracellulare mycobacterium xenopei. Lancet (7558): 36, 1968

In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones. Chemioterapia 6(6): 431-433, 1987

The activity of azaquinone cqq against clinical isolates of mycobacterium avium mycobacterium intracellulare and mycobacterium fortuitum and mycobacterium chelonae complex. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 338, 1992

In vitro activity of ciprofloxacin and ofloxacin against mycobacterium tuberculosis mycobacterium avium mycobacterium africanum mycobacterium kansasii and strains of bcg. Immunitaet und Infektion 14(6): 203-207, 1986

Ci 960 pd127391 or am 1091 sparfloxacin win 57273 and isepamicin activity against clinical isolates of mycobacterium avium mycobacterium intracellulare complex mycobacterium chelonae and mycobacterium fortuitum. Diagnostic Microbiology & Infectious Disease 15(2): 169-172, 1992

Monoclonal antibodies for the rapid differentiation of mycobacterium tuberculosis from mycobacterium bovis mycobacterium avium mycobacterium kansasii and mycobacterium xenopi. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 139, 1988

Dna relatedness among selected strains of mycobacterium tuberculosis mycobacterium bovis mycobacterium bovis bcg mycobacterium microti and mycobacterium africanum. International Journal of Systematic Bacteriology 35(2): 147-150, 1985

Comparative in vitro activity of newer macrolides against mycobacterium fortuitum and mycobacterium chelonae and mycobacterium avium complex. Abstracts of the Annual Meeting of the American Society for Microbiology 90: 3, 1990

Heat stable enz acid phosphatase activity of mycobacteria mouse mycobacterium kansasii mycobacterium avium mycobacterium intracellulare mycobacterium fortuitum mycobacteria marinum mycobacterium runyonii. Japanese Journal of Bacteriology 22(9): 519-521, 1967

Disinfection of bronchoscopes, contaminated in vitro with Mycobacterium tuberculosis, Mycobacterium avium-intracellulare and Mycobacterium chelonae in sputum, using stabilized, buffered peracetic acid solution ('Nu-Cidex'). Journal of Hospital Infection 37(2): 137-143, 1997

Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. International Journal of Systematic and Evolutionary Microbiology 54(Pt 5): 1653-1667, 2004